BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23059819)

  • 1. p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling.
    Nayak G; Cooper GM
    Cell Death Dis; 2012 Oct; 3(10):e400. PubMed ID: 23059819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling.
    Terragni J; Nayak G; Banerjee S; Medrano JL; Graham JR; Brennan JF; Sepulveda S; Cooper GM
    J Biol Chem; 2011 Oct; 286(42):36215-27. PubMed ID: 21873430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.
    Huo X; Liu S; Shao T; Hua H; Kong Q; Wang J; Luo T; Jiang Y
    J Biol Chem; 2014 Sep; 289(36):24759-70. PubMed ID: 25053419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors.
    Terragni J; Graham JR; Adams KW; Schaffer ME; Tullai JW; Cooper GM
    BMC Cell Biol; 2008 Jan; 9():6. PubMed ID: 18226221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53.
    Charvet C; Wissler M; Brauns-Schubert P; Wang SJ; Tang Y; Sigloch FC; Mellert H; Brandenburg M; Lindner SE; Breit B; Green DR; McMahon SB; Borner C; Gu W; Maurer U
    Mol Cell; 2011 Jun; 42(5):584-96. PubMed ID: 21658600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.
    Zhang YX; Liu XM; Wang J; Li J; Liu Y; Zhang H; Yu XW; Wei N
    Cancer Biol Ther; 2015; 16(6):965-75. PubMed ID: 25893985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway.
    Pap M; Cooper GM
    Mol Cell Biol; 2002 Jan; 22(2):578-86. PubMed ID: 11756553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
    Qi W; Weber CR; Wasland K; Savkovic SD
    BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
    Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH
    J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1).
    Wrede CE; Dickson LM; Lingohr MK; Briaud I; Rhodes CJ
    J Biol Chem; 2002 Dec; 277(51):49676-84. PubMed ID: 12393870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma.
    Bloedjes TA; de Wilde G; Maas C; Eldering E; Bende RJ; van Noesel CJM; Pals ST; Spaargaren M; Guikema JEJ
    Blood Adv; 2020 Sep; 4(17):4151-4164. PubMed ID: 32898245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1.
    Zhang M; Zhang J; Chen X; Cho SJ; Chen X
    Genes Dev; 2013 Oct; 27(20):2246-58. PubMed ID: 24142875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.
    Singh S; Ramamoorthy M; Vaughan C; Yeudall WA; Deb S; Palit Deb S
    Cell Death Differ; 2013 Apr; 20(4):558-66. PubMed ID: 23238568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis.
    Adlakha YK; Saini N
    Cell Death Dis; 2013 Mar; 4(3):e542. PubMed ID: 23492773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JNK- and AKT/GSK3β- signaling pathways converge to regulate Puma induction and neuronal apoptosis induced by trophic factor deprivation.
    Ambacher KK; Pitzul KB; Karajgikar M; Hamilton A; Ferguson SS; Cregan SP
    PLoS One; 2012; 7(10):e46885. PubMed ID: 23056511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
    Nair VD; Olanow CW
    J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGF inactivates forkhead family transcription factor by activation of Akt in glomerular mesangial cells.
    Ghosh Choudhury G; Lenin M; Calhaun C; Zhang JH; Abboud HE
    Cell Signal; 2003 Feb; 15(2):161-70. PubMed ID: 12464387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3.
    Allard D; Figg N; Bennett MR; Littlewood TD
    J Biol Chem; 2008 Jul; 283(28):19739-47. PubMed ID: 18458087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
    Biswas SK; Zhao Y; Sandirasegarane L
    Mol Vis; 2009 Aug; 15():1599-610. PubMed ID: 19693287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against potassium deprivation-induced apoptosis involves the Akt pathway and inhibition of cell cycle reentry.
    Yeste-Velasco M; Folch J; Casadesús G; Smith MA; Pallàs M; Camins A
    Neuroscience; 2009 Mar; 159(3):1135-47. PubMed ID: 19356694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.